Xcovery Holdings, Inc.

11780 US Hwy. One, Ste. 202
Palm Beach Gardens,  FL  33408

United States
http://www.xcovery.com/
  • Booth: 16161

Focused on ALK+ Non-small cell lung cancer (NSCLC), Xcovery, a biopharmaceutical company working to improve the lives of patients with cancer. Xcovery is currently enrolling patients with prior crizotinib and/or alectinib for its Phase 2 clinical trial. In addition, Xcovery is enrolling patients and sites for its Phase 3 clinical trial in tyrosine kinase inhibitor naïve ALK+ NSCLC patients.


  •  
  •      
     

  •  
  •